Enanta Pharmaceuticals Company

Enanta’s chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus (RSV), hepatitis B virus (HBV), non-alcoholic steatohepatitis (NASH), human metapneumovirus (hMPV) and SARS-CoV-2. Learn more about our research.

Funding Status: N/A
Headquarters: United States
Number Of Exists: N/A
Founded Date: N/A
Technology: COVID
Industry: Genomic and Epigenominc Instabillity
Investor Type: N/A
Investment Stage: N/A
Employee Number: N/A